Global Drug Report 2017-2026: Entrectinib (Roche/Chugai/Nerviano)
Dublin, July 05, 2019 (GLOBE NEWSWIRE) -- The "Entrectinib" report has been added to ResearchAndMarkets.com's offering. Entrectinib (Roche/Chugai/Nerviano) is a selective tyrosine kinase inhibitor (TKI) of the tropomyosin receptor kinases ( …